Clicky

Halozyme Therapeutics, Inc.(HALO) News

Date Title
Oct 14 Implied Volatility Surging for Halozyme Therapeutics (HALO) Stock Options
Oct 3 Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE®
Oct 2 High Growth Tech Stocks In The United States To Watch
Sep 16 FDA approves Roche’s Ocrevus Zunovo with Halozyme Enhanze delivery tech
Sep 13 Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis
Sep 13 Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer
Sep 10 Q1 2025 Avid Bioservices Inc Earnings Call
Jul 30 Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
Jul 29 5 Biotech Stocks to Bet On Bright Industry Prospects
Jul 26 This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Jul 23 Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term
Jul 23 Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy
Jul 23 Halozyme to Report Second Quarter 2024 Financial and Operating Results
Jun 25 Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Jun 24 Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years
Jun 21 Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy
May 16 Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 10 Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
May 9 The 3 Best Biotech Stocks to Buy in May 2024
May 8 Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript